These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 1909632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. LDL apheresis activates the complement system and the cytokine network, whereas PCSK9 inhibition with evolocumab induces no inflammatory response.
    Lappegård KT, Enebakk T, Thunhaug H, Ludviksen JK, Mollnes TE, Hovland A.
    J Clin Lipidol; 2016; 10(6):1481-1487. PubMed ID: 27919366
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis].
    Sattler AM, Bock K, Schmidt S, Maisch B, Schaefer JR.
    Z Kardiol; 2003; 92(Suppl 3):III64-7. PubMed ID: 14663605
    [Abstract] [Full Text] [Related]

  • 8. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D, Mellwig KP.
    Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [Abstract] [Full Text] [Related]

  • 9. Effect of heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) apheresis on hepatitis C plasma virus load.
    Schettler V, Monazahian M, Wieland E, Thomssen R, Müller GA.
    Ther Apher; 2001 Oct; 5(5):384-6. PubMed ID: 11778924
    [Abstract] [Full Text] [Related]

  • 10. [H.E.L.P. apheresis and oxidative stress].
    Pulawski E, Mellwig KP, Horstkotte D.
    Z Kardiol; 2003 Oct; 92(Suppl 3):III38-41. PubMed ID: 14663600
    [Abstract] [Full Text] [Related]

  • 11. Overview: techniques and indications of LDL-apheresis.
    Bosch T, Gurland HJ.
    Biomater Artif Cells Immobilization Biotechnol; 1991 Oct; 19(1):1-18. PubMed ID: 1751662
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F, Jaeger BR, Oberhoffer M, Reichart B, Seidel D.
    Z Kardiol; 2003 Oct; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [Abstract] [Full Text] [Related]

  • 13. [A comparative and technical assessment of the HELP system (heparin extracorporeal LDL precipitation) and cascade filtration (CF) for the treatment of high plasma lipids].
    Loschiavo C.
    G Ital Nefrol; 2013 Oct; 30(3):. PubMed ID: 23832475
    [Abstract] [Full Text] [Related]

  • 14. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D.
    Z Kardiol; 2003 Oct; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [Abstract] [Full Text] [Related]

  • 15. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, Laughlin LO.
    Am J Cardiol; 1995 Jun 01; 75(16):1124-9. PubMed ID: 7762498
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
    Mo JK, Li YX, Lei D, Wu DH.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar 01; 22(3):278-9. PubMed ID: 12390791
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reverse flux filtration: a new mode of therapy improving the efficacy of heparin-induced extracorporeal LDL precipitation in hyperlipidemic hemodialysis patients.
    Bosch T, Samtleben W, Thiery J, Gurland HJ, Seidel D.
    Int J Artif Organs; 1993 Feb 01; 16(2):75-85. PubMed ID: 8486416
    [Abstract] [Full Text] [Related]

  • 20. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
    Jaeger BR, Bengel FM, Odaka K, Uberfuhr P, Labarrere CA, Bengsch S, Engelschalk C, Kreuzer E, Reichart B, Schwaiger M, Seidel D.
    J Heart Lung Transplant; 2005 Dec 01; 24(12):2022-30. PubMed ID: 16364844
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.